Scientists test cannabis compound with popular Weight-Loss drugs
Disease control
Completed
This early-stage study tested the safety and initial effects of a new formulation of cannabidiol (CBD) when given alone and in combination with common diabetes/weight-loss medications (GLP-1 agonists). It involved 148 overweight or obese adults, some with pre-diabetes or type 2 d…
Phase: PHASE1 • Sponsor: Lexaria Bioscience Corp. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC